Related Experiment Video
Updated: Oct 23, 2025

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Liver, Renal, and Cardiovascular Failure After Unintentional Overdose of Tizanidine in a 2-Year-Old Child
Insights
Tizanidine overdose in a child with spastic quadriplegia caused severe liver, kidney, and cardiovascular failure. This case highlights the risks of high-dose tizanidine in pediatric patients, especially with comorbidities and dehydration.
Area of Science:
- Pharmacology
- Pediatric Critical Care
- Toxicology
Background:
- Tizanidine, an alpha-2 adrenergic agonist, is approved for adult spasticity but used off-label in pediatrics.
- Gradual dose titration is standard in adults; however, overdose risks in children are less understood.
- Comorbidities like spastic quadriplegia and dysphagia can complicate pediatric treatment.
Purpose of the Study:
- To report a case of severe tizanidine overdose in a pediatric patient.
- To highlight the potential for serious organ dysfunction following accidental high-dose tizanidine administration in children.
- To emphasize the importance of careful dosing and monitoring in pediatric patients with spasticity.
Main Methods:
- Case report of a 2-year-old male with spastic quadriplegia and dysphagia.
- Documented accidental overdose of tizanidine (1.6 mg/kg/day) after clonazepam withdrawal and nasogastric tube dislodgement.
- Clinical presentation, laboratory findings (hepatic and renal dysfunction), and supportive treatment in the pediatric intensive care unit were analyzed.
Main Results:
- The patient presented with hemodynamic instability, altered consciousness, and severe dehydration.
- Blood tests indicated significant hepatic and renal dysfunction.
- Diagnosis was liver, renal, and cardiovascular failure secondary to tizanidine overdose, exacerbated by dehydration.
Conclusions:
- Tizanidine overdose can lead to critical organ failure in pediatric patients.
- Dehydration and underlying comorbidities significantly worsen the outcomes of tizanidine overdose.
- This case underscores the need for cautious tizanidine use and close monitoring in the pediatric population.
Abstract:
Tizanidine is a central alpha-2 adrenergic receptor agonist indicated for the treatment of spasticity in adults; however, its use in the pediatric population is considered off-label. In adults, the dose is gradually titrated until the desired reduction in muscle tone is achieved. Hypotension is a frequent adverse effect, but impaired liver function is not characteristic of alpha-2 adrenergic agonist overdose. We report a 2-year-old male affected with spastic quadriplegia (treated with clonazepam and tizanidine) and dysphagia (he was fed by nasogastric tube). Two days before admission caregivers ran out of clonazepam so they increased the tizanidine dose from 0.15 mg/kg/day to 1.6 mg/kg/day. Simultaneously his nasogastric tube fell out; therefore, he was unable to maintain proper oral nutrition and hydration. He presented to the emergency department hemodynamically unstable, with impaired consciousness and signs of severe dehydration. Blood tests revealed hepatic dysfunction without cholestasis and renal dysfunction. He was transferred to the pediatric intensive care unit. Treatment was mainly supportive, apart from tizanidine discontinuation. Metabolic and infectious diseases were ruled out so he was finally diagnosed as having liver, renal, and cardiovascular failure after tizanidine overdose, worsened by dehydration. His clinical status improved, and after 3 weeks he was discharged from the hospital, receiving clonidine instead of tizanidine to treat spasticity. Tizanidine overdose can result in serious complications that can be worsened because of patient comorbidities.
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Factors Affecting Drug Response: Overview
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

